Moreover, a genetic polymorphism study in the Chinese population also demonstrated a correlation between the metabolic control and ApoA5 gene in patients with NAFLD [21], but whether the serum ApoA5 level is associated with metabolic syndrome and NAFLD remains unknown. This evidence concerns the gene APOA5 and metabolic dysfunction-associated steatotic liver disease.